WEST PHARMACEUTICAL SERVICES INC Annual Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
West Pharmaceutical Services Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • West Pharmaceutical Services Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $32.4M, a 10.2% increase year-over-year.
  • West Pharmaceutical Services Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $105M, a 9.85% decline year-over-year.
  • West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2023 was $122M, a 6.63% increase from 2022.
  • West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2022 was $115M, a 7% increase from 2021.
  • West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2021 was $107M, a 47.9% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $122M +$7.6M +6.63% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $115M +$7.5M +7% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $107M +$34.7M +47.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $72.5M +$13.5M +22.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $59M +$17.6M +42.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 $41.4M -$39.5M -48.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $80.9M +$26.5M +48.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $54.4M +$28.1M +107% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $26.3M -$20.9M -44.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 $47.2M +$7M +17.4% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $40.2M +$7.5M +22.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 $32.7M +$9.2M +39.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-25
2011 $23.5M +$9.9M +72.8% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-27
2010 $13.6M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.